Medivir AB announced that Jens Lindberg will assume his position as CEO on January 24, 2022. Magnus Christensen, who has been interim CFO since the Annual General Meeting on May 5, 2021 will remain as CFO of Medivir. Jens Lindberg joins Medivir from his current position as VP Commercial at Sedana Medical, where he also served as acting CEO of the company during second-third quarter of 2021.

Prior to that, during his twenty-five years at AstraZeneca, Jens held numerous roles, spanning local and global areas of responsibility. In the later years at AstraZeneca, his roles were primarily in the area of oncology with responsibility for developing global product strategy and global commercial responsibility in product development. Jens was also responsible for running the local Business Unit Oncology in Nordic-Baltic region with significant commercial success.